Background: The importance of appropriate serum 25-hydroxy vitamin D [25(OH)D] for multiple health measures is widely described, however, the prevalence of vitamin D deficiency remains remarkably high. The goal of our study is to explore the distribution of vitamin D deficiency among an elective total joint arthroplasty (TJA) population within a lower latitude climate with relatively abundant sunshine. We hypothesize this group will demonstrate a high prevalence of vitamin D deficiency, thus exposing a potential opportunity to improve outcomes with proper identification and management.
metabolism of vitamin D, or "sunshine vitamin," has been challenged. [1, 2] Historic vitamin D recommendations unfortunately reflect only the modern "normal" reference range for serum 25- 
hydroxy vitamin D [25(OH)D]. [3]
Those who spend a significant amount of time outdoors, for example, farmers and construction workers, likely reflect a true physiologic normal reference range; a range humans evolved to optimally function within. Popular recommendations regarding sunscreen, skin coverage, and sun avoidance have further discouraged our natural vitamin D synthesis. Many experts now believe moderate sun exposure, or heliotherapy, should be sought rather than avoided, with beneficial influences on blood pressure, general well-being, and balancing the sleep-wake cycle. [1, 4] However, controlled sun exposure is an unreliable means of generating adequate synthesis of this unique vitamin. Regional variations in climate and cultural practices can significantly impact serum 25(OH)D. Even in temperate climates like Honolulu, Hawaii, over half of otherwise healthy patients have demonstrated sub-optimal vitamin D indices. [5] The importance of appropriate serum 25(OH)D on multiple health measures is widely described. Vitamin D supplementation reveals direct dose-response improvements in bone mineral density, fracture prevention, and lower extremity strength and function. [3, 4, 6, 7] A serum 25(OH) D within normal limits is associated with a decreased risk of microbial infections, falls, numerous cancers, multiple sclerosis, cardiovascular disease, autoimmune diseases, and diabetes mellitus. [6] [7] [8] [9] [10] Standardized management of vitamin D deficiency could potentially have profound effects on health care costs and morbidity related to countless chronic diseases. [6, 11] The high prevalence of vitamin D deficiency in those undergoing orthopedic surgery is well described. [12] However, limited studies exist documenting vitamin D deficiency in the elective arthroplasty group, particularly in a subtropical climate. The goal of our study is to explore the prevalence and distribution of vitamin D deficiency among an elective total joint arthroplasty (TJA) population within a lower latitude climate with relatively abundant sunshine. We hypothesize a continued high prevalence of vitamin D deficiency within this population, exposing a potential opportunity to improve outcomes with proper management.
Materials and Methods
From January to December, 2014, serum 25(OH)D levels were collected during a standard preoperative workup prior to primary or revision joint arthroplasty by the senior author (H.D.S.) in South Carolina. Mean serum 25(OH)D, seasonal variation, and patient demographics were recorded. We defined Vitamin D deficiency consistent with the current Endocrine Society classification: serum 25(OH)D < 20 ng/ml, 21-29 ng/ml, and 30-100 ng/ml representing deficiency, insufficiency, and normal, respectively. Posttraumatic primary joint replacement and revision secondary to periprosthetic joint infection (PJI) were excluded to limit confounding variables. The association between vitamin D classification and study group was tested with Fisher's exact test. Non-parametric Mann Whitney Wilcoxon tests with t-approximation two-tailed tests were used for intergroup comparisons.
Results
A total of 308 patients underwent evaluation. 46.8% (144) of the participants were female, and 89.6% (276) identified as Caucasian. The mean patient age was 68. serum 25(OH)D (28.5ng/ml) compared to those under 65 (30.7ng/ml)(p=.12). As expected, serum 25(OH)D demonstrated variation throughout the year: January to March, April to June, July to September, and October to December recorded 28.5 ng/ml, 31.73 ng/ml, 36.57 ng/ml, and 23.03 ng/ml 25(OH)D, respectively (figure 2). July recorded the highest monthly average serum 25(OH)D with 40.11 ng/ ml, while February recorded the lowest reaching 25.2 ng/ ml.
Discussion
Our results demonstrate the majority (53.8%) of an otherwise classically low risk population based on latitude [13] and race [14] present with at least vitamin D insufficiency prior to undergoing elective total joint arthroplasty. Our findings reinforce previous findings regarding seasonal variations in serum 25(OH)D. [15] Additionally, while not significant, our findings lend support to the well described natural physiologic age dependent decline in serum 25(OH)D. [16] Non-white patients over 65 years of age during the winter months were at the greatest risk of vitamin D deficiency.
A majority of patients undergoing elective orthopedic surgery have demonstrated vitamin D insufficiency, with orthopedic trauma patients at a higher risk. [9, 12] One study reported 77.7% of hip fracture patients had sub-normal serum 25(OH)D versus 58.6% in normal controls. [17] Furthermore, periprosthetic joint infections (PJI) show a close association with vitamin D deficiency in the arthroplasty population. [9] Emerging evidence also suggests vitamin D plays a significant role in antimicrobial activity. [7, 8, 18 ,19] Numerous advantages of maintaining appropriate serum 25(OH)D continue to emerge, however, appropriate management remains controversial. [7, 18, 20, 21] Multiple dosing protocols have been evaluated. [20, 21] One study suggested daily requirements of at least 1,600 IU D3 for optimal serum levels. [21] This dose was further analyzed in a randomized placebo control trial, where the mean serum 25(OH)D increased from 20.6 ng/ml to 33.7 ng/ml in the treatment group, but declined to 18.5 ng/ ml in the control group. [20] However, while encouraging, these findings suggest that even 1,600 IU D3 daily may fail to achieve the optimal serum threshold. Load and maintenance dosing is recommended when deficiency is identified. [10, 22] Bolus dosing as high as 500,000 IU D3 with maintenance doses of 50,000 IU D3 monthly have demonstrated safe and rapid serum 25(OH)D normalization. Many experts believe 30 ng/mL 25(OH)D reflects a minimum threshold for both skeletal and non-skeletal benefits, with an optimal range between 36 and 40 ng/ml. [2] [3] [4] [20] [21] [22] The Endocrine Society recommends 1500-2000 IU D3 daily to meet these goals, and 50,000 IU D2 or D3 weekly for 8 weeks is recommended when deficiency is identified. [10] Surgical site infections (SSIs) in the setting of TJA can have catastrophic consequences. [23] The vitamin D pathway is intimately involved in antimicrobial activity through both the innate and acquired immune response. [8, 19] For example, interferon-gamma (IFN-y) , a key antimicrobial mediator, is only induced in vitamin D-sufficient sera, with vitamin D receptor (VDR) induction required for antimicrobial peptide expression. [8] Additionally, tolllike receptors (TLRs), a key mediator of the innate immune system, demonstrate a key interplay with the vitamin D pathway. [19] Human macrophages appear to up-regulate VDR and vitamin D-1-hydroxylase genes inducing antimicrobial peptides like cathelicidin to eradicate microbial infections. Compared to Caucasian sera, AfricanAmerican sera demonstrate significantly lower cathelicidin induction and antimicrobial peptide expression. Vitamin D supplementation for one year in both African-Americans and Caucasians in one study corrected the serum 25(OH)D discrepancy (24.1 ng/ml versus 37.2 ng/ml) after just two months of treatment, reaching a final 67.7 ng/ml and 67.3 ng/ml at one year, respectively. [2] Furthermore, a significantly higher prevalence of vitamin D deficiency was found in patients undergoing revision TJA for PJI compared to both primary TJA and aseptic loosening revision groups, with 13.29 ng/ml versus 20.52 ng/ml, respectively. [9] Interestingly, serum 25(OH)D shows an inverse relationship with C-reactive protein, although the significance of this relationship is not completely understood. [12, 24] As a cross sectional analysis, this study has several inherent limitations. First, we are unable to assess specific trends in serum 25(OH)D. Therefore, perioperative and long term outcomes associated with specific serum 25(OH) D are not revealed. In a addition, specific comorbidities and preoperative vitamin supplementation were not recorded. Our population was also largely Caucasians, which may have substantial influences on the generalizability of our findings. Other modes of diagnosis and treatment including intact vitamin D [18] and 25(OH)D3 (HyD) [7] are on the horizon and show encouraging results. Further research is needed to investigate the association between vitamin D deficiency, appropriate treatment thresholds, and specific orthopedic outcomes. Current evidence supports normalizing Vitamin D levels in the perioperative period with potentially reduced patient length of stay and SSIs in the orthopedic population. [25] At our institution we have developed a perioperative protocol based on a pre-operative serum 25(OH)D evaluation. Those with serum 25(OH)D under 35 ng/ml receive 5,000 IU D3 daily beginning 2 weeks prior to surgery, with re-evaluation the day of surgery. Patients with a serum 25(OH)D <30ng/ml the day of surgery receive 50,000 IU D2 weekly for 8 weeks, followed by 2000 IU D3 daily indefinitely. Endocrinology referral is warranted for continued vitamin D deficiency.
Conclusion
Our results demonstrate the majority (53.8%) of an otherwise classically low risk patient population present with at least vitamin D insufficiency prior to undergoing elective total joint arthroplasty, with elderly non-white patients in the winter months at the highest risk. Appropriate vitamin D management is associated with favorable influences on both skeletal and non-skeletal outcomes. Potential complications of TJA, including periprosthetic joint infection and aseptic loosening, can possibly be decreased with proper identification and treatment. Appropriately designed studies are needed to fully elucidate the importance of vitamin D in short and long term outcomes within the total joint arthroplasty population.
